Page last updated: 2024-10-16

aminolevulinic acid and Kaposi Sarcoma

aminolevulinic acid has been researched along with Kaposi Sarcoma in 6 studies

Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.

Research Excerpts

ExcerptRelevanceReference
"We have reviewed the results of clinical investigations into the use of photodynamic therapy (PDT) with intravenous injection of hematoporphyrin derivative (HpD), Photofrin (PF) and Sn-protoporphyrin (Sn-Pp) or oral administration of delta-aminolevulinic acid in the treatment of skin cancers and/or psoriasis."4.79Photodynamic therapy with systemic administration of photosensitizers in dermatology. ( Calzavara-Pinton, PG; Ortel, B; Szeimies, RM; Zane, C, 1996)
"Bowen's disease was highly responsive, provided that adequate light and HpD or PF doses were delivered."2.39Photodynamic therapy with systemic administration of photosensitizers in dermatology. ( Calzavara-Pinton, PG; Ortel, B; Szeimies, RM; Zane, C, 1996)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Fonda-Pascual, P1
Fernandez-Gonzalez, P1
Sanchez-Los Arcos, L1
Alcantara-Nicolas, F1
Lopez-Galan, C1
Canseco-Martin, M1
Vidal-Asensi, S1
Park, MY1
Kim, YC1
Calzavara-Pinton, PG1
Szeimies, RM2
Ortel, B1
Zane, C1
Jongen, AJ1
Sterenborg, HJ1
Orenstein, A1
Kostenich, G1
Malik, Z1
Karrer, S1
Hohenleutner, U1
Landthaler, M1

Reviews

2 reviews available for aminolevulinic acid and Kaposi Sarcoma

ArticleYear
Photodynamic therapy with systemic administration of photosensitizers in dermatology.
    Journal of photochemistry and photobiology. B, Biology, 1996, Volume: 36, Issue:2

    Topics: Aminolevulinic Acid; Bowen's Disease; Breast Neoplasms; Dermatology; Dihematoporphyrin Ether; Female

1996
Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy.
    American journal of clinical dermatology, 2001, Volume: 2, Issue:4

    Topics: Aged; Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Clinica

2001

Other Studies

4 other studies available for aminolevulinic acid and Kaposi Sarcoma

ArticleYear
Treatment of cutaneous Kaposi sarcoma with methylaminolevulinate photodynamic therapy: A case series.
    Photodermatology, photoimmunology & photomedicine, 2020, Volume: 36, Issue:5

    Topics: Adult; Aged, 80 and over; Aminolevulinic Acid; Humans; Male; Photochemotherapy; Photosensitizing Age

2020
Classic Kaposi sarcoma treated with intralesional 5-aminolevulinic acid injection photodynamic therapy.
    Archives of dermatology, 2009, Volume: 145, Issue:10

    Topics: Aged; Aminolevulinic Acid; Biopsy, Needle; Follow-Up Studies; Foot; Humans; Immunohistochemistry; In

2009
Mathematical description of photobleaching in vivo describing the influence of tissue optics on measured fluorescence signals.
    Physics in medicine and biology, 1997, Volume: 42, Issue:9

    Topics: Aminolevulinic Acid; Animals; Biophysical Phenomena; Biophysics; Condylomata Acuminata; Fluorescence

1997
The kinetics of protoporphyrin fluorescence during ALA-PDT in human malignant skin tumors.
    Cancer letters, 1997, Dec-09, Volume: 120, Issue:2

    Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorescence; Humans; Photoche

1997